US Edition
Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer
- Ginkgo Bioworks announced on May 21, 2025, from Boston that Steven Coen will succeed Mark Dmytruk as Chief Financial Officer effective May 30, 2025.
- Mark Dmytruk decided to resign to accept another position after leading Ginkgo's finance team through multiple transformation phases.
- Steven Coen, a CPA with over 30 years of accounting and finance experience, joined Ginkgo on May 1, 2023 and previously held senior roles at Charles River Laboratories.
- Jason Kelly, Ginkgo's co-founder and CEO, thanked Mark for his service and expressed confidence in Steven's ability to steward finance toward the company's strategic goals.
- Mark established a strong finance organization that laid the foundation to achieve Adjusted EBITDA breakeven by 2026, and Steven aims to build on this financial vision.
27 Articles
27 Articles
LoudounTimes.com
Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer
BOSTON, May 21, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and biosecurity, today announced that Mark Dmytruk, the Company's Chief Financial Officer, intends to resign from his…
Ginkgo Bioworks Appoints Steven Coen as CFO
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Mark Dmytruk, the Company’s Chief Financial Officer, intends to resign from his role at the Company on May 30, 2025 to accept a position at another organization and Steven Coen, CPA, the Company’s Chief Accounting Officer, will become Chief Financial Officer, effective upon Mr. Dmytruk’s resignation. Mr. Coen joined the …
Coverage Details
Bias Distribution
- 55% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
